University of California, San Francisco | UCSF Center for Colitis and Crohn's Disease

Research site
1701 Divisadero St, San Francisco, California, United States of America
Site insights

Top conditions

Ulcer (3 trials)

Ulcerative Colitis (3 trials)

Colitis (3 trials)

Crohn Disease (2 trials)

Top treatments


Parent organization

This site is a part of University of California, San Francisco

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site


2 of 5
Status: Active
Trial type: Interventional
Funder type: Industry

A Maintenance and Long-Term Extension Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Participants With Crohn's Disease Who Completed the Studies M14-431 or M14-433

A multicenter study to evaluate the efficacy and safety of maintenance and long-term treatment administration of upadacitinib, an orally administered...

Active, not recruiting
Crohn's Disease
Drug: Upadacitinib
Drug: Placebo for Upadacitinib

The purpose of this study is to evaluate safety and efficacy of risankizumab in participants with ulcerative colitis (UC) in participants who respond...

Active, not recruiting
Ulcerative Colitis (UC)
Drug: risankizumab
Drug: placebo for risankizumab

Trial sponsors

AbbVie logo

AbbVie (4 trials)

Clinical trials

Find clinical trialsTrials by location


© Copyright 2024 Veeva Systems